Milan, Italy

Francesco De Santis

This inventor holds 2 USPTO granted patents. Top assignees: Italfarmaco Spa, Sanofi Sa. Active years: 1992-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco De Santis. Retrieved from https://idiyas.com/inventor/francesco-de-santis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Francesco De Santis: Innovator in Pharmaceutical Compositions

Introduction

Francesco De Santis is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and processes. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Francesco's latest patents include "Glycosaminoglycan salts and pharmaceutical compositions containing them" and "Process for preparing EDTA-free heparins, heparin fractions and fragments." These inventions focus on creating heparins that are characterized by a low EDTA content and reduced bleeding effects, showcasing his commitment to advancing pharmaceutical safety and efficacy.

Career Highlights

Throughout his career, Francesco has worked with prominent companies such as Italfarmaco Spa and Sanofi S.A. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Francesco has collaborated with esteemed colleagues, including Giancarlo Sportoletti and Alma Dal Pozzo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Francesco De Santis stands out as a dedicated inventor in the pharmaceutical field, with a focus on improving drug formulations and processes. His contributions continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…